The new tool is part of a package that also includes posters and SMS texts to support veterinary practices in raising awareness of gastric ulcers to horse owners.
Equine Gastric Ulcer Syndrome (EGUS) is a serious and common condition and any type of horse can be at risk.1 EGUS can have a profound impact on a horse’s condition and performance and can be life threatening in foals. It is a challenging condition to diagnose as the clinical signs are often vague and not always present.1
Gastroscopy is the only method currently available for a definitive diagnosis. Of the two types of disease equine squamous gastric disease is graded on a numeric scale with 1 being the least severe and 4 being the most serious. Equine glandular gastric disease can be very varied in terms of location and type so grading this disease on a score system is no longer recommended. Instead it is now usually described in terms of location, severity and appearance.2
The new tool has been designed to help vets to map the area affected by gastric disease and record the details in an accessible format. This information, together with treatment and management recommendations, can be shared easily with the client. Posters explaining gastric ulceration have been designed to help increase awareness and understanding of EGUS amongst horse owners.
Zoetis says effective treatment usually involves a combination of management and medical treatments. UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.3 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.3,4 One syringe contains enough UlcerGold for a daily dose for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
References
The RCVS is advising all practices that it is not currently carrying out a data-gathering exercise and that phone calls prompting the return of a survey, and requesting mobile phone numbers, are not being made on behalf of the College.
The warning comes after several practices have called the College to query 'feedback forms' - supposedly issued in relation to the Practice Standards Scheme or the payment of members' retention fees.
The practices were asked to return forms which they had not received, and also to provide mobile phone numbers, by someone who claimed to work for the 'statutory regulator' or 'the RCVS'. Contact phone numbers left by the caller were either RCVS fax numbers or numbers which looked like RCVS direct dial numbers, but were not.
Lizzie Lockett, Head of Communications, said: "This looks like an exercise to gain mobile phone numbers which is being carried out in the College's name. We are currently investigating who might be making these calls. In the meantime, if a practice receives such a call, it would be helpful if they could take down a name and contact number and let us know."
Ring 020 7202 0725 or email l.lockett@rcvs.org.uk to report any suspicious activity.
ATOP 7 Mousse and PYOclean Mousse are presented as a ‘dry shampoo’ in foam form for cats and dogs. They join the company's Dermoscent portfolio of companion animal products, developed to help with the management of scaling disorders, atopic or allergic skin disease and infections.
Both products contain a blend of plant extracts and essential oils from Hemp seed, which LDCA says has a moisturising and restructuring action on the skin. Atop 7 contains lemon tea tree extract, which the company says boosts anti-inflammatory and anti-pruritic activity. PYOclean contains lavender and manuka, which are claimed to have an anti-bacterial action.
LDCA says it has designed the two non-rinse mousses with owner compliance in mind; that used twice-weekly twice-weekly alone or in combination with other supplements or treatments as part of a skincare protocol, they can extend the time between shampoos. They can also be applied quickly to speed patients’ discharge from hospital or used when animals are boisterous or dislike baths.
According to the company, a 2-week veterinary-supervised study looking at the effect of ATOP 7 Mousse on the skin of flea-allergic and atopic dogs, reported a veterinarian general satisfaction score of 8.7/10. Owners of the dogs on the trial reported an 8.7/10 general satisfaction score and a similar score for the product’s ability to soothe irritated skin.¹
The full Dermoscent range, including the new mousses, is available through Vet Direct as well as Henry Schein (selected products) or as a special order through Centaur. ATOP 7 Mousse and PYOclean Mousse are both available in 150ml packs and are priced at £7.94 + VAT each (list price).
For more information visit: http://www.dermoscent.com. A clinical case study by Dr Jean-Loup Mathet on the use of PYOclean Shampoo, Spray and Mousse in a 14-year old West Highland White Terrier with chronic, recurrent, inflammatory, pruritic and seborrhoeic dermatosis is also available online or by request.
Reference
Special interest groups on VetSurgeon are areas where discipline-specific news, forum discussions, CPD events and clinical images are curated in one place. They also help members with shared interests connect with each other and interact with experts in the field.
In the Small Animal Medicine Group, I am delighted to welcome two contributing experts. Firstly, Andy Kent from Willows Referral Centre, who is already well-known on VetSurgeon for his helpful, knowledgeable and thoughtful contributions. Secondly, the pharmacist Andrea Tarr who, as the founder of Veterinary Prescriber, is something of a font of knowledge.
All VetSurgeon members with an interest in small animal medicine are warmly invited to come and join the new group. You need to login, navigate to the section here, and press the 'join' button on the left hand side (you may need to rotate your mobile phone to see it). You can also subscribe to a monthly or weekly digest of content added to the section.
Whilst you're there, I'm going to offer a bottle of good wine (ie not any old plonk) to the member who starts the most interesting discussion in the forum over the next couple of weeks. It could be a general topic, or, better yet, an interesting case discussion. If the latter, it doesn't matter how old it is. If you have an interesting case in your personal archives, dig it out and share it!
Don't forget ... sharing content and contributing to the discussion it starts (or indeed just reading content in the group) can count towards your annual CPD requirement. Just click the 'Claim CPD' button at the top of the page and the system will keep a record of the page you were on, the time you spent and how you found it useful.
The Small Animal Medicine Group is the second special interest group launched so far, after the Small Animal Dentistry Group. Watch this space, there are more on the way ...
The survey of 97 cat owners and 156 vets conducted in June last year found that currently only 30% of cat owners give supplements to their cat but 74% would be willing to try them.
The survey also found that whilst 80% of vets thought the main reasons to be hesitant about recommending feline supplements were palatability and the owner’s ability to give products, owners were less concerned about the ease of giving the supplement (53%), and more concerned about the cost (45%) and being unsure of the benefits (39%).
Tara Evans RVN, head of sales at Vita, said: “It is interesting that the majority of vets believe that practicalities around administering oral supplements is the main drawback to giving these products, whereas only 53% of owners were concerned about this.
"Understanding owner concerns regarding efficacy and price could help vets support more owners to move forward with supplements for their cats.”
According to the survey, the most frequently used supplements, by both vets and owners are those made to support joints.
Cat owners also showed an interest in giving supplements for general wellness (61%).
Tara added: “Owners are open to supplementing for general health, as well as more specific health-related issues.”
www.vitaanimalhealth.com
Avid, the maker of pet microchip indentification products has developed its registration system so that Avid MicroChips can now be registered via practice management software using the VetXML schema.
This instantly registers the microchip directly on to the UK PETtrac Database, managed by Avid. All the implanter needs to do is add the microchip number to the client record, then click to register.
The practice has the option to print a receipt for the client before they leave the surgery, and a certificate confirming the registration will be posted to the client by PETtrac, usually the same day.
The microchip registration is completed in real time on the UK PETtrac Database, and is automatically checked to ensure the microchip being registered was sold to the practice completing the registration. In the event of any errors, the practice will be contacted by PETtrac to obtain the correct information.
Simon Clark, IT developer for Avid said "Avid already has direct registration via a number of practice management software packages and we are working with others to get this feature implemented as soon as possible. Registrations are now easier and quicker than ever before, and really can be completed with just one click!"
For full details about how the Avid microchip system can benefit your practice please contact the Avid sales office on 0800 652 7 977 or visit www.avidplc.com
Kruuse UK has announced that it will be launching its new Android telemetric ECG system at BEVA 2011.
The original Televet 100 supports transmission of ECG data to a range of approx 100m (330ft), allowing recording and displaying of real time data only within a confined lunging or riding arena. By linking this system to a mobile network via 3G Android phone and a Windows 7 based tablet PC, the new Televet system overcomes this range limitation.
The new system requires the rider/horse to carry a 3G mobile phone which transmits data over the mobile internet, allowing the veterinary surgeon to display and record real time data on any PC/laptop with internet access or mobile internet connection. This also includes GPS information collected by the phone allowing the ECG, heart rate and velocity of the horse to be displayed in parallel.
The Android Telemetric ECG system is specifically targeted towards veterinary applications in the field of sports horses where extended range is particularly useful, such as endurance riding, three day eventing and racing.
Televet software can now also be integrated in Dicom infrastructures in practice for data capture and recording.
Sarah Stokes, Kruuse Equine Territory Manager said: "the flexibility and simplicity of the system along with immediate access to ECG data of patients will be an invaluable diagnostic tool for UK vets allowing vital support for patients and owners wherever they are."
Visitors to the Kruuse stand at BEVA 2011 will also have the chance to win an Acer ICONI W500 tablet worth £500.
MSD Animal Health UK has announced the launch of Bravecto, which it says is the first and only treatment available for fleas and ticks in dogs that is rapidly effective and offers 12-weeks duration of efficacy.
Bravecto (fluralaner) is the first of a new generation of systemically active ectoparasiticides, the isoxazolines, and will only be available on prescription through veterinary practices. The new product will be available in five strengths of pork liver flavoured palatable chew for different size dogs - one chew per weight band - which MSD says are readily accepted from the hand. Jolian Howell, marketing and technical lead at MSD Animal Health UK said: "Bravecto is a truly unique and exciting innovation which will transform the effective treatment of fleas and ticks - providing protection like never before from a single dose. It is the first in a new generation of products that offer a full 12-week protection and will help keep the treatment of fleas and ticks within veterinary practices."
He continued: "Estimates suggest that flea and tick treatments are applied for just 2.8 months per year so just one dose of Bravecto will immediately deliver much improved levels of treatment for dogs in veterinary care, which is good for the animal and good for the vet." MSD Animal Health says it is investing in the launch of Bravecto with a major marketing and practice support package which aims to raise awareness of fleas and ticks and drive pet owner footfall into practices for flea and tick control.
The new product will be available after BSAVA Congress, where MSD will be giving visitors the opportunity to learn more about it.
The report is the culmination of the work of a joint RCVS and VSC BAME Student Support Working Group, set up to explore key issues in supporting BAME veterinary students during their studies.
The Working Group made a total of 14 recommendations, which included:
Stephanie-Rae Flicker is a recent Royal Veterinary College (RVC) graduate who co-chaired the Working Group alongside Professor Rob Pettitt from the University of Liverpool.
She said: “I hope this encourages and supports our veterinary institutions to actively implement change regarding discrimination faced during studies and placements, nurturing role models and helping affected students develop sense of belonging and community during their studies and beyond.
"Many thanks to all that have contributed to the completion of this Report – we hope the recommendations have a lasting impact, and benefit those both already present and yet to enter our profession."
RCVS/VSC BAME Student Support Working Group Report.
The 1st Reproduction Control Guidelines of the World Small Animal Veterinary Association (WSAVA) have just been accepted for publication and are expected to recommend a move away from a blanket neutering policy.
Dr Neil Mottram BSc (Hons) BVSc MRCVS Technical Manager at Virbac said: "This webinar will help clinicians understand and navigate the latest evidence-based medicine in regards to neutering.
"The panel of world-leading experts on reproduction will present their guidance on medical and surgical neutering and offer delegates the opportunity to interact with a live Q&A section at the end of the event.
https://app.livestorm.co/virbac-france/1st-reproduction-control-guidelines?type=detailed
Mr Seymour-Hamilton was originally struck off in 1994 after his Kent practice was found to be unhygienic and unsterile with poor record keeping.
However, he has always maintained that the reason his premises were unhygienic and unsterile was because they were closed.
As in previous applications, he said his reason for applying for restoration was to help him gain recognition for his alleged herbal and natural remedy discoveries and that he had no intention of going back into general practice.
As with previous applications, the Committee said that Mr Seymour-Hamilton has shown no real insight into the conduct underlying the original findings and nor has he shown insight into matters identified by previous restoration hearings.
The Committee also considered that Mr Seymour-Hamilton has been off the Register for some 31 years and would therefore need prolonged, intensive, formal retraining to ensure that he was now fit to practise, without which he might pose a risk to animal welfare.
Mr Seymour-Hamilton's case was not helped by the fact that he indicated that he had practised veterinary surgery while off the Register – including conducting two spay procedures in Calais, France, and treating two of his own dogs for cancer.
He also referred to having cultured faecal bacteria in a witness’ kitchen.
The Committee felt it was concerning that Mr Seymour-Hamilton thought these things were compatible with being on the Register and upholding the professional standards expected of a veterinary surgeon.
Paul Morris, chairing the Committee and speaking on its behalf, said: “Mr Seymour-Hamilton still lacks an understanding as to why he has not been restored in the past.
"Apart from additional CPD, he has not set about effectively addressing any of his shortcomings.
"He relies passionately on his research, yet he does not support that research with any peer-reviewed publications, indeed all his attempts to gain recognition have been rebuffed.”
He added: “The Committee is firmly of the view that after such a prolonged period of failing to be reinstated as a veterinary surgeon, Mr Seymour-Hamilton has to face the reality that his continued applications, taking up time, resources and expense (which is ultimately borne by all those veterinary surgeons who are on the Register), are vexatious and ultimately unlikely to succeed.
“Whilst the College cannot prevent him from continuing to apply to be restored to the Register, Mr Seymour-Hamilton should by now realise that this is not a good use of the College’s finite resources.
"He is now 86 years old and has not practised for over thirty years and in fact has now been off the Register for longer than he was on it.
"This is now the twelfth time he has been found to be not fit to be restored to the Register.
"The Committee hopes Mr Seymour-Hamilton will now take time seriously to reflect and take into account the impact to all concerned of his continued applications, before deciding to submit any more.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
A research project funded by The Horse Trust has discovered that a racehorse's performance does not markedly change after it has recovered from a tendon injury.
The research was led by Bryan O'Meara, who is in the final year of a three year clinical training scholarship funded by The Horse Trust.
Mr. O'Meara carried out the research at Donnington Grove Veterinary Surgery in Newbury, under the supervision of epidemiologist Dr Tim Parkin from University of Glasgow.
Tendonitis is one of the most common musculoskeletal injuries in racehorses, with a prevalence of 11-30%, according to earlier research.
Mr. O'Meara examined the clinical records and racing histories of 400 racehorses who had been treated for superficial digital flexor (SDF) tendonitis injuries over a five year period (2003-2008).
The race records of horses affected by tendon injury were compared with 400 matched control horses that had never suffered SDF tendon injuries.
The controls were horses training in the same establishment at the time of injury and of the same age and sex as the case horse.
The research looked at the performance of the racehorses in races before and after treatment for the injury, and at the performance of the control horses before and after the treatment date. The Racing Post Rating (RPR), which is published by the Racing Post after every race, was used as a measure of performance.
Mr. O'Meara found that there was no significant difference in RPR before and after the treatment date in case and control horses.
According to The Horse Trust, this result is unexpected as in vitro studies have found that healed tendon tissue has reduced elasticity due to the presence of scar tissue. This suggests that a horse with a healed SDF tendon would need to work its muscles harder to compensate and would therefore be expected to have lower performance.
Mr. O'Meara said more research is needed to back-up his finding that performance isn't significantly affected by tendon injury: "It could be that using Racing Post Rating to measure performance isn't sensitive enough to pick up a change in the horse's performance. However, it's encouraging that there's no marked change in performance after a horse has recovered from a tendon injury. These findings show that there's no need to give up on a horse that has a tendon injury - they can still come back and perform well, or can be used for other, less demanding riding activities."
The research also found that there was no significant difference between case and control horses when returning to racing and completing three races. Only after completing five races, or three years post treatment, was a significant difference found between case and control horses. This finding is a step towards developing a more accurate assessment of tendon treatment. Outcome after five races or three years post treatment is a better indicator of the outcome of treatment.
Mr. O'Meara said: "At the moment, some tendon treatments state their success as the percentage of horses that return to racing after treatment. However, we've shown that there's no significant difference between case and control horses at this time. At the moment, there are a myriad of treatments available to treat tendonitis. Hopefully this finding will be used in further research to learn which treatments are most effective."
Mr O'Meara's research also found a link between SDF tendon injury and the racehorse competing at its maximum performance level: the case horses were significantly nearer to their pre-injury maximum performance level in the race immediately before injury (compared to matched controls), suggesting that they were competing nearer their individual maximum performance level when the SDF tendon injury occured.
Petplan has launched a new system through which veterinary staff at Appointed Representative (AR) practices can activate 4 weeks Immediate Veterinary Cover (IVC) for clients' puppies, kittens and rabbits at www.petplanvet.co.uk.
Petplan says the new system will greatly improve its service to the veterinary industry, enabling same day information transfer, reducing the amount of paperwork and admin for veterinary staff as well as ruling out the chances of paperwork getting lost or delayed in the post.
Simon Masding, Petplan Head of Sales and Partnerships said: "Petplan has the most established cover note scheme in the market and due to the strength of our brand and the products we offer is able to generate more insured clients for practices than any other provider. Our team of Account Executives visit practices across the UK on a daily basis which means we understand the pressures of day-to-day practice life. Our new online IVC service is just one of the innovative ways we try to make things easier for veterinary staff so they can focus on looking after clients and their pets."
For more information about becoming a Petplan AR practice, and Immediate Veterinary Cover, call Petplan's Vetline on 0800 316 8800.
Any practices that activate IVC online at petplanvet.co.uk before 31st July 2012 will be entered into a prize draw to win an iPad.
The British Equine Veterinary Association (BEVA) has clarified regulations on equine dental procedures following a survey which showed confusion, even amongst vets, over who is allowed to do what in a horse's mouth.
In the survey of BEVA members, more than half were unaware of the dentistry techniques that equine dental technicians (EDTs) are permitted to perform and the levels of veterinary supervision required.
In response, the association has put together a new information leaflet which explains the regulations surrounding equine dental care and describes where recommended practice differs from the letter of the law.
All diagnostic and treatment procedures in the horse's mouth are Acts of Veterinary Surgery under the Veterinary Surgeons Act 1966. The only exception is the manual removal of small dental overgrowths and sharp enamel points with hand instruments.
However it is acknowledged that there are a limited number of procedures that, despite being considered Acts of Veterinary Surgery, may be delegated safely to suitably qualified EDTs without compromising the horse's welfare and safety. In 2009 the RCVS, with assistance from BEVA, BVDA and BAEDT, listed these processes and categorised all dental procedures into three groups:
Despite there being no legal basis supporting non-vets performing Category 2 procedures, the RCVS has stated that there would be no public interest in prosecuting vets who collaborate with suitably qualified EDTs to perform non-invasive (Categories 1 and 2) procedures.
BEVA recommends that, for their own protection, all vets who deal with horses:
Vicki Nicholls, equine vet at Wright and Morten in Cheshire, chair of BEVA council's Paraprofessional Committee and member of the British Association of Equine Dental Technicians (BAEDT) said: "The lack of awareness is alarming and clearly emphasises the need to make vets and equine dental technicians fully conscious of current regulations regarding equine dentistry. Non-adherence to the regulations is a serious matter and could lead to prosecution of the veterinary surgeon, EDT and/or owner."
The number of vets taking the BEVA/BVDA exam in equine dentistry has increased in recent years with about 15% of those who have passed the exam being vets. BEVA says this is indicative of the growing awareness, amongst owners and vets, of the importance of dental health. It also reflects a desire to develop and demonstrate both practical skills and a theoretical understanding of equine dental care to augment the vet's broader medical knowledge. Expertise in equine dental care has, for many veterinary practices, become a valuable asset.
Copies of the dental regulations information leaflet can be downloaded from the BEVA website at www.beva.org.uk. BEVA also runs regular dentistry CPD courses, details of which can be found on the website.
Image source: Rachel C from Scotland
The RCVS has announced the candidates standing in the RCVS Council and Veterinary Nurses Council elections this year and is inviting veterinary surgeons and nurses to put their questions to them directly for a video reply.
There are eleven candidates standing for election to RCVS Council in 2015. Overall there are six men and five women, which include two existing Council members eligible for re-election and nine new candidates. They are:
Three veterinary nurses are standing in this year's VN Council elections, including one existing VN Council member eligible for re-election. They are:
Ballot papers and candidates' details are due to be posted to all veterinary surgeons and veterinary nurses eligible to vote during the week commencing 16th March, and all votes must be cast, either online or by post, by 5pm on Friday, 24 April 2015.
Once again the College is inviting members of both professions to 'Quiz the candidates' by putting their questions directly to all those standing for election. Each candidate will then be invited to choose two questions to answer from all those received, and produce a video or audio recording of their answers. All recordings will be published on the RCVS website on Thursday 19 March.
Vets and nurses should email their question (NB one per person) to vetvote15@rcvs.org.uk or VNvote15@rcvs.org.uk, or post it on twitter using the hashtags #vetvote15 or #VNvote15, respectively, by midday on Monday 9 March.
Gordon Hockey, RCVS Registrar said: "It's important that members of the veterinary professions choose who they want to sit on their governing Councils, so we always try to make the elections as interesting and engaging as possible.
"This year, we hope the provision of short videos, to accompany the usual written information, will encourage people to find out a little more about all those standing for election, and then use their vote."
The session will be conducted in the style of the BBC Radio 4 Moral Maze discussion programme, with panelists and witnesses arguing for and against the viewpoint corporatisation is inevitable and will benefit vets and their clients.
Moderated by Madeleine Campbell, Keith Chandler and Karl Holliman will argue for corporatisation and Andrew Harrison and Tim Greet will be against. They will call upon a series of 'witnesses' for detailed questioning before the topic is more broadly debated.
CVS, the UK’s biggest veterinary group now owns more than 410 veterinary practices, of which over 30 are specifically equine or mixed practices.
The latest equine acquisitions include Bell Equine, a one-site Equine Referral Hospital in Kent, in January 2017 and Severn Edge Veterinary Group, a mixed practice with 12 sites in Shropshire, including a six-vet dedicated equine practice, in April 2017.
One line of argument says that the commercial and business advantages of a corporate, together with their scale and diversity, can give veterinary surgeons greater potential for a more flexible career path and advancement within the industry, and a more sustainable working career in equine practice.
On the flip side, there's the removal of any opportunity to buy into ownership, reduced decision-making ability because of adherence to corporate procedures, extra paperwork, longer approval processes and an increased emphasis on the bottom line.
David Mountford, Chief Executive of BEVA said: "The auditorium is usually full to bursting for our Moral Maze sessions because they bring a broader and more engaging dimension to important topics. The statement Corporatisation of equine practices is inevitable and will benefit vets and their clients is bound to generate some stimulating and possibly heated debate."
This year's BEVA Congress will be held at Liverpool Arena Convention Centre, and anyone who registers before 3rd August will receive significantly reduced booking fees.
For more information, visit: www.beva.org.uk.
Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.
The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.2
According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence. Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.5 This quality of evidence is, says Hill's, in contrast to many supplements.
John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."
Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis1, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.
Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.
Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk or http://www.hillspetmobility.ie/
Ceva Animal Health UK, makers of Feliway for cats and Adaptil for dogs, has launched an online petition calling for the Government to force all fireworks manufacturers to carry information about pet and wildlife safety both online and on packaging and is calling for the veterinary industry to back the campaign.
Ceva says the campaign is designed to highlight the stress that Bonfire Night can cause to pets: according to the company's research more than 80 per cent of owners say their pet is afraid of the noises associated with firework season.
The petition states: Over 80 per cent of pet owners have a pet that is afraid of fireworks. Fireworks manufacturers need to accept their responsibilities and publicise pet safety information on packaging and on their websites. Adaptil call (sic) on the Government to make this a mandatory requirement.
However, that rather beggars the question: "What pet safety information?" After all, there isn't that much pet and wildlife information you can fit on packet of bangers (especially after you've added the elf 'n safety information for half-wits, like: "This product may go bang"). So perhaps the amount of pet and wildlife safety information that could be included on a firework would be limited to something like: 'Remember to check there aren't any pets about before using this firework'. But that's something most concerned pet owners do anyway, and adding the instruction to the side of a firework surely isn't going to make a blind bit of difference.
Nevertheless, Sarah Endersby at Ceva Animal Health UK, said: "This will be the second year running we have called upon the fireworks industry to recognise its responsibilities when it comes to protecting pets and wildlife during what is the most stressful season for them. For example, many dogs find fireworks distressing and may go on to develop noise phobia.
"Many owners will seek advice from pet specialists such as vets, vet nurses, pharmacists and pet shop staff. However, by producing warnings on the packaging, fireworks manufacturers can also help advise and guide pet owners to minimise the stress caused to pets."
Ceva has also produced a range of materials for fireworks to help educate owners on firework fear and how to calm and soothe their pets. There's a marketing pack which can be placed in veterinary practices which includes leaflets, a leaflet dispenser, stickers, bunting and notice-board materials.
To request a pack, please email retailuk@ceva.com or call Ceva on 01494 781 510
You'd better hope though that Ceva isn't too successful with its campaign to highlight the stress caused to pets by fireworks. If people really do become more careful about how they use fireworks, nobody will need to buy Adaptil or Feliway!
The BVA has released more results from the Voice of the Profession survey, which show that 67% of vets have seen dogs that needed conformation altering surgeries and caesareans in the last year.
Every year the Kennel Club receives over 3,200 data submissions from both vets and dog owners about conformation altering surgeries and caesareans carried out on Kennel Club registered dogs. Sharing data about conformation altering surgeries and caesareans is vital to help build a picture of the current situation, and facilitate measures to improve health and welfare for future generations of dogs.
The information collected by the Kennel Club provides details of breeding lines appearing to perpetuate certain defects. For example, data submitted for caesareans prevents the registration of puppies born to a bitch that has already had two litters delivered by caesarean section while data submitted for conformation altering surgeries allows the Kennel Club to make decisions on whether or not to allow affected dogs to be entered for shows.
In the longer term, measures implemented by the Kennel Club will include analysis of all submitted data to create a research database that will provide an evidence-base to influence the future of dog welfare.
When asked about operations carried out on Kennel Club registered dogs, the majority of vets said that they do submit data on conformation altering surgeries (60%) and caesareans (65%) however 15% of survey respondents revealed that they never submit data. Those vets who do not always report gave ‘time’ as the main reason for not doing so.
BVA is working with its members to raise awareness of the Kennel Club’s new online system, which takes a few minutes to complete, to encourage a data drive that could reduce avoidable hereditary problems, prevent further lifelong discomfort and suffering, and improve health and welfare for dogs.
BVA President Sean Wensley said: "Vets are seeing concerning trends in dog health and welfare, especially with the current public want for designer dogs and brachycephalic breeds, so the need for a record of conformation altering surgeries and caesareans carried out in daily practice has never been more important. Owners can submit data on their dogs’ operations yet data from veterinary practices is vital for the Kennel Club’s evidence base as it offers additional validity that many owners are not able to provide, ensuring robust and informative data for now and the future."
Other reasons vets gave for not always submitting data on conformation altering surgeries and caesareans, included:
BVA is urging vets and practice teams to recognise the importance of submitting this data and to work with their clients to ensure delivery of the best welfare outcomes for dogs. To support its members, BVA has compiled FAQs on conformation altering surgery and will be taking further questions to the Kennel Club Dog Health Group. To assist with the process of data submission in daily practice, BVA has developed a poster that can be downloaded at www.bva.co.uk/dog-breeding.
Together, these two cancers account for almost a third of all canine cancers.
Dr. Heather Wilson-Robles, an Associate Professor at Texas A&M University and Chief Medical Officer of Volition Veterinary Diagnostics said: "The proof of concept results in these two very prevalent canine cancers give us confidence to move forward with other Nu.Q Vet assays in our pipeline, and with the larger range of cohorts and trials we have collected and planned.
"Clearly, we still have work to do as this single assay did not detect one of the other top five canine cancers, canine osteosarcoma, which was the third cancer tested in this study. However, I am delighted to see such positive results in these two significant cancers and look forward to reporting further data over the coming quarters with additional Nu.Q Vet assays, this time tested on an automated platform.”
Dr. Terry Kelly, Chief Scientific Officer of Volition America said: “It is exciting to see such strong results from our first Nu.Q Vet study conducted at Texas A&M University Veterinary Hospital. It is also interesting to note the similar patterns of detection seen in both canine and human samples confirming that the Nu.Q platform does appear to be useful in more than just human diagnostics.
"As with human diagnostics, there are currently no accurate, simple, affordable cancer screening tests available in veterinary medicine and yet 25% of dogs will develop cancer at some stage of their life. I look forward to completing the planned trials and to launch our first Nu.Q Vet product in the U.S. that we expect to occur in 2020."
RCVS President, Dr Jerry Davies, has committed to prioritise the establishment of a new Audit and Risk Committee, following publication of the recommendations of a report into two overspends at the College.
Earlier this year, outgoing President Peter Jinman had announced that a review would be carried out into the circumstances that led to higher-than-expected expenditure on the College's new database and building development works in the Lower Ground Floor at Belgravia House.
The RCVS Officer team asked Professor Bill McKelvey - a member of the College's Governance Review Group - and two of the College's Privy Council-appointed Council members to look at all aspects that related to its budgeting and expenditure process of those projects, and propose lessons that should be learned.
Dr Davies said: "That such a review was required is regretted, but I would like to thank Professor McKelvey, Richard Davis and Judith Webb for their diligence in this work. Their recommendations will be a very helpful addition to the work that is currently underway to ensure corporate governance is fit for purpose and, in particular, that the management of capital projects within the College is optimised."
The full Overspend Report (one sentence was redacted on legal advice) was considered by Council at its meeting on 3 November. Council agreed that the recommendations should be made public. The College is currently seeking further legal advice on whether it is proper for the report to be made available under the Freedom of Information Act.
Dr Davies added: "The recommendations of the report are under consideration by a group of five past Presidents, together with Richard Davis and Judith Webb as lay members of Council, under the Chairmanship of Peter Jinman, and their proposals will be considered by Council in due course.
"The recommendation that an Audit and Risk Committee be set up will be prioritised, as this was highlighted as an imperative. Other related activities, such as the development of a protocol for the management of major projects, had already been put in place by Officers prior to the overspend review."
Regarding the two projects at the heart of the report, the College says building work in the Lower Ground Floor at Belgravia House has been complete for some time and the new rooms and their facilities are being used, particularly when Disciplinary Committee hearings render much of the rest of the building out of bounds. The new data management system is also in use and an external consultant is currently looking at the work that has been carried out so far, and will make recommendations for the future.
"Meanwhile, although there are many lessons to be learned from the report, it's business as usual in terms of bringing to a conclusion many of our important ongoing initiatives, such as the introduction of the new Code of Professional Conduct, the consultations on the recommendations of the Specialisation Working Party and a draft Performance Protocol, and, of course, the ongoing work of the Disciplinary and Preliminary Investigation Committees," said Dr Davies.
The recommendations of the report, which were adopted by Council, can be downloaded from www.rcvs.org.uk/McKelvey.
Extensively updated, the new edition reflects the increasing sophistication of reptile medicine and surgery and acknowledges the expanding range of reptile species kept as companion animals.
Part one covers the husbandry aspects of reptile care, including captive maintenance and nutrition, plus a new chapter dedicated to anatomy and physiology.
Part two contains the details necessary to carry out successful clinical examination, anaesthesia, surgery (including endoscopy), treatment (including emergency and critical care), non-invasive imaging, laboratory testing and post-mortem examinations, as well as humane euthanasia.
Part three addresses disease by organ system, covering parasitology and infectious disease.
New to this third edition are also chapters on marine turtle rehabilitation and crocodilians, as well as updates on the handling of venomous reptiles.
Simon Girling said: "This third edition of the BSAVA Manual of Reptiles is another milestone in the commitment of the BSAVA to exotic species medicine. Reptile medicine and surgery is now being accepted as a mainstream discipline within the veterinary world, reflected in the growing number of textbooks and the appearance of postgraduate qualifications."
BSAVA says the new manual will benefit both the general practitioner seeing a small number of reptiles or a more specialist practitioner dealing with these species on a daily basis.
The first phase of research is being conducted this January and February 2023 and will analyse the amount and distribution of UK canine health research funding over the past decade.
Veterinary associations, societies and charities which support canine health research tend to identify funding priorities aligned with their own strategy and scope, taking account of independent peer review from experts in the field of research.
However, the RVC says that as there are many research funders working independently, some important research topics may be overlooked and separately funded projects can inadvertently overlap in their work.
This study endeavours to investigate these issues and consider how resources are prioritised across different areas of canine research.
Participating stakeholders will be asked their opinions on future research funding and this information will contribute to developing a long-term strategy for not-for-profit UK canine health research.
Thereafter, the aim is to create a pilot consultation process for developing a central prioritisation platform for future collaborative canine research.
The RVC’s says it has already got data and support from several major funders but is keen to maximise the scope of this research, so it is now looking for participation from specialist veterinary societies that fund research, and non-university organisations, such as charities, corporates or independent referral practices which conduct their own in-house canine research.
Dr Alison Skipper, Postdoctoral Researcher into Canine Research Funding within VetCompass at the RVC said: “We are really keen to hear from as many non-profit organisations involved with canine health research funding as possible. The breadth and depth of this data is vital to ensure that our findings accurately reflect this sector."
For more information about how to get involved, please visit https://rvc.uk.com/canine-research-funding-analysis.
The company conducted the survey of 404 owners after news that the bio-pharma company Okava plans to trial a weight-loss drug for dogs that mimics the effects of weight-loss drugs like Wegovy, tapping into a potential $10 billion market.
Of the pet owners who responded, it was the younger group aged 25-34 who were most receptive to the idea of a weight-loss drug for their pet (56%).
That figure fell to 21% of 45–54-year-olds and 20% among those aged 55 and above, most of whom were probably holding up their hands in horror: "Whatever next".
Alicia Hempsted, pet insurance spokeswoman from MoneySuperMarket, said: “If GLP-1 style treatments for obesity become available for dogs in the future, it’s likely that owners will have to pay out of pocket for them, which may affect their availability."
https://www.moneysupermarket.com/pet-insurance/
Photo: www.depositphotos.com
Dechra Veterinary Products has added to its Veterinary Essentials range of veterinary-licensed post-patent products with the launch of Fiprocat and Fiprodog, a fipronil spot-on solution for the treatment and prevention of on-animal flea infestations in cats and dogs.
Available in packs of 3 or 6 pipettes, Fiprocat and Fiprodog are only distributed through the veterinary channel. Dechra highlights the product's convenient self-standing pipette. which it says makes the process of applying the spot-on easier.
Dechra says it offers a wealth of client support material, and practice promotional support to go with the product.
Fiprocat and Fiprodog can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
Rob Simpson at Dechra said: "Fipronil has been used in the treatment and prevention of on-animal flea infestations for many years and is one of the most commonly used treatments in practice. Fiprocat and Fiprodog join R.I.P Fleas Extra to offer a cost effective complete flea solution to tackle both on-animal and environmental flea infestations."